MOTS-c - MOTS-c is a small mitochondrial-derived peptide (16 amino acids) that regulates metabolism, enhances insulin sensitivity, and helps cells respond to metabolic stress
The default protocol I prescribe is at-home, subcutaneous or intramuscular
CagriSema is a combination strategy: It pairs cagrilintide, a long-acting amylin analog, with semaglutide, a GLP-1 receptor agonist
Transparency: Good suppliers clearly state peptide purity (should be 95%+ for AOD 9604), provide batch numbers, and offer detailed product information
For a compound still working through its trial program, that consistency is hard to ignore
The treatment requires monitoring by healthcare professionals to ensure safety and effectiveness [1]